Recruiting

Observational Study

Sponsor:

University of Utah

Code:

NCT07648953

Conditions

HPV Vaccination

Eligibility Criteria

Sex: All

Age: 18 - 26

Healthy Volunteers: Not accepted

Interventions

Microvideos: HPV Vaccination Education

Study Details

Brief summary:

This exploratory mixed-methods study aims to examine receipt of treatment and decision-making among rural cancer patients in Utah. Guided by Conceptual Model of Healthcare Access, the study will integrate, survey and cancer registry data with patient interviews to better understand how travel burden, socioeconomic conditions, health literacy, and other contextual factors shape treatment location and access to care . While the setting of this research is specific to Utah, a state with vast rural regions and only one National Cancer Institute (NCI)-designated cancer center, the findings may inform policy and practice improvements in other states with similar geographic and healthcare infrastructure. Thus, the study has potential relevance for advancing rural cancer equity nationwide.

Understanding how rural cancer patients make treatment decisions is essential to addressing persistent disparities in cancer care access and outcomes. While geographic barriers and structural inequities are well-documented, less is known about the individual and contextual factors that shape patients' choices about where and how to receive treatment. This mixed-methods study will examine receipt of treatment, decision-making, and patient experience among rural cancer patients in Utah, with attention to travel burden, referral pathways, health literacy, and perceived barriers to care.

Conditions

HPV Vaccination

Study ID

NCT07648953

Start date

Aug, 2026

Status verified date

May, 2026

Completion date

May, 2027

Anticipated

Primary completion date

May, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 26

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Eligible participants include cancer survivors who are currently ages 18-26 years and who were diagnosed with childhood cancer (ages 0-26 at diagnosis) in the past ten years.
  • Currently use Facebook or willing to create a Facebook account to use for the duration of the study.
  • At the time of enrollment, have not completed all recommended doses of the HPV vaccine.

Exclusion Criteria:

  • Unable to speak and understand English.
  • Participants who take part in the Aim 1 focus groups will be ineligible for the Aim 2 social media group.
  • Participants who are fully vaccinated for HPV will be ineligible as the goal of Aim 2 is to evaluate the feasibility of the social media campaign for improving vaccine intention among HPV unvaccinated individuals.

Study Design

Enrollment

55 participants

Anticipated

Intervention Model

Single group

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

other: HPV Vaccination Education

Microvideos are designed to be <2 minutes long and to address key information on a topic in an engaging and concise manner. HPV vaccine education will be provided to unvaccinated emerging adult survivors of childhood cancer through a pilot quasi-experimental social media intervention.

Interventions

Microvideos: HPV Vaccination Education

To educate survivors of childhood cancers about a key cancer prevention strategy, HPV vaccination. The core microvideos will focus on the 5 Ws of HPV vaccination: Who should get vaccinated, What HPV vaccination protects against, When to get vaccinated, Where to access the vaccine, Why it matters-designed particularly for cancer survivors.

Primary outcome measure

  • Feasibility of Microvideo education [ Time Frame: up to 4 weeks ]

Central Contacts and Locations

Central contacts

Echo Warner, MPH, PhD, SB

801-244-7040echo.warner@hci.utah.edu

Locations

University of Utah

Recruiting

Salt Lake City, Utah, United States, 84112

Contacts

Echo Warner, MPH, PhD, SB

801-244-7040echo.warner@hci.utah.edu

Principal Investigator:

Echo Warner, MPH, PhD, SB

More Information

Sponsor

University of Utah

Last update posted

Aug 6, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Utah on 2026-08-06.